CITIGROUP INC - IMMUNOPRECISE ANTIBODIES LTD ownership

IMMUNOPRECISE ANTIBODIES LTD's ticker is IPA and the CUSIP is 45257F200. A total of 15 filers reported holding IMMUNOPRECISE ANTIBODIES LTD in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of IMMUNOPRECISE ANTIBODIES LTD
ValueSharesWeighting
Q3 2023$13
-38.1%
70.0%0.00%
Q2 2023$21
+10.5%
70.0%0.00%
Q1 2023$19
-47.2%
70.0%0.00%
Q4 2022$3670.0%0.00%
Q3 2022$070.0%0.00%
Q2 2022$070.0%0.00%
Q1 2022$070.0%0.00%
Q4 2021$070.0%0.00%
Q3 2021$070.0%0.00%
Q2 2021$070.0%0.00%
Q1 2021$070.0%0.00%
Q4 2020$070.00%
Other shareholders
IMMUNOPRECISE ANTIBODIES LTD shareholders Q4 2020
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 1,058,035$2,9310.15%
Gradient Capital Advisors, LLC 26,808$74,2580.03%
WEST PACES ADVISORS INC. 1,665$4,6120.00%
DIMENSIONAL FUND ADVISORS LP 28,652$79,3660.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 17,484$48,4300.00%
CITIGROUP INC 7$190.00%
MORGAN STANLEY 533$1,4760.00%
NATIONAL BANK OF CANADA /FI/ 2,255$6,2510.00%
WOLVERINE TRADING, LLC 11,700$330.00%
View complete list of IMMUNOPRECISE ANTIBODIES LTD shareholders